Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Ravi B. Parikh; Blythe J.S. Adamson; Sean Khozin; Matthew D. Galsky; Shrujal S. Baxi; Aaron Cohen; Ronac Mamtani

doi:10.1001/jama.2019.10650

Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Ravi B. Parikh, Blythe J.S. Adamson, Sean Khozin, Matthew D. Galsky, Shrujal S. Baxi, Aaron Cohen, Ronac Mamtani

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	1209-1211
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	322
Issue number	12
DOIs	https://doi.org/10.1001/jama.2019.10650
State	Published - 24 Sep 2019

Access to Document

10.1001/jama.2019.10650

Cite this

@article{ab501edb12db431a88c5ad5fba73907c,

title = "Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer",

author = "Parikh, {Ravi B.} and Adamson, {Blythe J.S.} and Sean Khozin and Galsky, {Matthew D.} and Baxi, {Shrujal S.} and Aaron Cohen and Ronac Mamtani",

note = "Funding Information: Conflict of Interest Disclosures: Dr Eikermann reported receiving unrestricted funds from philanthropic donors Jeffrey and Judy Buzen and grants from Merck. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by grants from the Conquer Cancer Foundation (Dr Parikh) and grants 5-T32-CA009615 (Dr Parikh) and K23-CA187185 (Dr Mamtani) from the National Cancer Institute of the National Institutes of Health.",

year = "2019",

month = sep,

day = "24",

doi = "10.1001/jama.2019.10650",

language = "English",

volume = "322",

pages = "1209--1211",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Association between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

AU - Parikh, Ravi B.

AU - Adamson, Blythe J.S.

AU - Khozin, Sean

AU - Galsky, Matthew D.

AU - Baxi, Shrujal S.

AU - Cohen, Aaron

AU - Mamtani, Ronac

N1 - Funding Information: Conflict of Interest Disclosures: Dr Eikermann reported receiving unrestricted funds from philanthropic donors Jeffrey and Judy Buzen and grants from Merck. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by grants from the Conquer Cancer Foundation (Dr Parikh) and grants 5-T32-CA009615 (Dr Parikh) and K23-CA187185 (Dr Mamtani) from the National Cancer Institute of the National Institutes of Health.

PY - 2019/9/24

Y1 - 2019/9/24

UR - http://www.scopus.com/inward/record.url?scp=85072561176&partnerID=8YFLogxK

U2 - 10.1001/jama.2019.10650

DO - 10.1001/jama.2019.10650

M3 - Letter

C2 - 31550019

AN - SCOPUS:85072561176

SN - 0098-7484

VL - 322

SP - 1209

EP - 1211

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 12

ER -